Canopy Growth Corporation (CGC) concluded trading on Wednesday at a closing price of $1.18, with 15.27 million shares of worth about $18.02 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -71.84% during that period and on April 16, 2025 the price saw a gain of about 16.83%. Currently the company’s common shares owned by public are about 154.83M shares, out of which, 154.03M shares are available for trading.
Stock saw a price change of 31.39% in past 5 days and over the past one month there was a price change of 0.85%. Year-to-date (YTD), CGC shares are showing a performance of -56.93% which decreased to -83.09% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.77 but also hit the highest price of $14.92 during that period. The average intraday trading volume for Canopy Growth Corporation shares is 7.53 million. The stock is currently trading 17.36% above its 20-day simple moving average (SMA20), while that difference is down -10.43% for SMA50 and it goes to -68.89% lower than SMA200.
Canopy Growth Corporation (NASDAQ: CGC) currently have 154.83M outstanding shares and institutions hold larger chunk of about 6.49% of that.
The stock has a current market capitalization of $182.70M and its 3Y-monthly beta is at 0.81. It has posted earnings per share of -$4.94 in the same period. It has Quick Ratio of 2.58 while making debt-to-equity ratio of 0.83. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CGC, volatility over the week remained 13.79% while standing at 11.33% over the month.
Stock’s fiscal year EPS is expected to rise by 49.26% while it is estimated to increase by 77.65% in next year. EPS is likely to grow at an annualized rate of 60.04% for next 5-years, compared to annual growth of 20.88% made by the stock over the past 5-years.
Coverage by Bernstein stated Canopy Growth Corporation (CGC) stock as an Underperform in their note to investors on November 02, 2022, suggesting a price target of $1.50 for the stock. Stock get an Underweight rating from Barclays on March 22, 2022.
